Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Emergent Biosolutions Inc (NYSE: EBS) closed at $7.72 down -16.72% from its previous closing price of $9.27. In other words, the price has decreased by -$16.72 from its previous closing price. On the day, 3.14 million shares were traded. EBS stock price reached its highest trading level at $9.0614 during the session, while it also had its lowest trading level at $7.715.
Ratios:
For a deeper understanding of Emergent Biosolutions Inc’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.23 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 2.52. For the most recent quarter (mrq), Quick Ratio is recorded 1.47 and its Current Ratio is at 2.88. In the meantime, Its Debt-to-Equity ratio is 1.33 whereas as Long-Term Debt/Eq ratio is at 1.32.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Rodman & Renshaw on August 22, 2024, initiated with a Buy rating and assigned the stock a target price of $16.
On March 07, 2024, The Benchmark Company Upgraded its rating to Buy which previously was Hold but kept the price unchanged to $5.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Nov 12 ’24 when DeGolyer Donald W sold 25,000 shares for $10.91 per share. The transaction valued at 272,750 led to the insider holds 111,100 shares of the business.
White Marvin L sold 14,287 shares of EBS for $171,015 on Nov 11 ’24. The Director now owns 54,092 shares after completing the transaction at $11.97 per share. On Nov 12 ’24, another insider, DeGolyer Donald W, who serves as the Director of the company, bought 25,000 shares for $11.77 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EBS now has a Market Capitalization of 418302016 and an Enterprise Value of 944401920. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.31 while its Price-to-Book (P/B) ratio in mrq is 0.82. Its current Enterprise Value per Revenue stands at 0.839 whereas that against EBITDA is -196.75.
Stock Price History:
Over the past 52 weeks, EBS has reached a high of $15.10, while it has fallen to a 52-week low of $1.42. The 50-Day Moving Average of the stock is -10.88%, while the 200-Day Moving Average is calculated to be 22.04%.
Shares Statistics:
For the past three months, EBS has traded an average of 2.39M shares per day and 2089760 over the past ten days. A total of 52.20M shares are outstanding, with a floating share count of 52.06M. Insiders hold about 3.93% of the company’s shares, while institutions hold 59.08% stake in the company. Shares short for EBS as of 1730332800 were 6948810 with a Short Ratio of 2.91, compared to 1727654400 on 8229525. Therefore, it implies a Short% of Shares Outstanding of 6948810 and a Short% of Float of 15.58.
